Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9357 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9357 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9291 |
High Similarity |
NPD1549 |
Phase 2 |
0.9257 |
High Similarity |
NPD1934 |
Approved |
0.9172 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9139 |
High Similarity |
NPD7075 |
Discontinued |
0.9122 |
High Similarity |
NPD4380 |
Phase 2 |
0.9067 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9067 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9032 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9032 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9032 |
High Similarity |
NPD6166 |
Phase 2 |
0.9013 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD6801 |
Discontinued |
0.8973 |
High Similarity |
NPD6799 |
Approved |
0.8861 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8851 |
High Similarity |
NPD1512 |
Approved |
0.8811 |
High Similarity |
NPD1510 |
Phase 2 |
0.8794 |
High Similarity |
NPD1240 |
Approved |
0.875 |
High Similarity |
NPD2796 |
Approved |
0.8742 |
High Similarity |
NPD6599 |
Discontinued |
0.8716 |
High Similarity |
NPD1511 |
Approved |
0.8701 |
High Similarity |
NPD3882 |
Suspended |
0.8693 |
High Similarity |
NPD2801 |
Approved |
0.8671 |
High Similarity |
NPD1607 |
Approved |
0.8667 |
High Similarity |
NPD5403 |
Approved |
0.8658 |
High Similarity |
NPD5401 |
Approved |
0.8636 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD3817 |
Phase 2 |
0.8634 |
High Similarity |
NPD6797 |
Phase 2 |
0.858 |
High Similarity |
NPD7251 |
Discontinued |
0.8571 |
High Similarity |
NPD7074 |
Phase 3 |
0.8562 |
High Similarity |
NPD7411 |
Suspended |
0.8533 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD7808 |
Phase 3 |
0.8509 |
High Similarity |
NPD7054 |
Approved |
0.8457 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8447 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8344 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.825 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8146 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8138 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8079 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7908 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7891 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD920 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7815 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7805 |
Intermediate Similarity |
NPD1247 |
Approved |
0.78 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7791 |
Intermediate Similarity |
NPD919 |
Approved |
0.7785 |
Intermediate Similarity |
NPD943 |
Approved |
0.7765 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7707 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7707 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7692 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7405 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7405 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7386 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7361 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7235 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7232 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1608 |
Approved |
0.723 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7205 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7184 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD37 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7166 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7143
|
Intermediate Similarity |
NPD6535 |
Approved |